EUVIMEDEuropean Health Evidence
Uhr Sources10/10 Journal Tree
Easy Demo

European Health Evidence

The European alternative to PubMed

EUVIMED is the European alternative to PubMed: a central, multilingual research platform for medicine, nursing, life sciences and healthcare. It brings together international and European literature sources, study registries, open-access full texts, citations and retraction notices in one search. Unlike pure bibliographic databases, EUVIMED supports the entire research process – from discovery and appraisal with LIVIA and CLARA to traceable evidence synthesis. European in focus, transparent, interoperable and designed for science and healthcare.

EuropeanMultilingualInteroperableTraceable

EUVIMED BETA

EUVIMED is currently in beta

EUVIMED is under continuous development. Features, data coverage and presentation may change or be temporarily incomplete.

Results are beta

Search results, classifications, summaries and AI-assisted assessments may be incomplete, delayed or incorrect.

Check original sources

Do not use EUVIMED results without verification for diagnosis, treatment or other clinical decisions. Always consult the original source and applicable guidelines.

Errors and feedback help us improve EUVIMED: info@euvimed.com

Lokaler Crossref-Datenbestand · journal-article

10.1177/1056789514562152

CrossRef Listing of Deleted DOIs · 2015

Vollständiger Abstract

Worum geht es in dieser Arbeit?

Relapsing-remitting multiple sclerosis (RRMS) exhibits clear sex-based disparities: females have higher incidence and inflammatory activity, whereas males have lower incidence, yet experience an accelerated disease course of neurodegeneration and disability accumulation. MicroRNAs (miRNAs). Key epigenetic regulators of immune and neuronal pathways may contribute to these differences, but sex is rarely examined as a primary biological variable in MS miRNA research. This exploratory pilot study characterized sex-specific miRNA expression in treatment-naïve individuals with RRMS using samples from 46 participants (17 males and 17 females with RRMS; 6 male and 6 female healthy controls) obtained from the Accelerated Cure Project biorepository. miRNA expression was quantified using the NanoString nCounter Human v3 panel, and differential expression (<i>p <</i> 0.05, fold-change ≥1.3) was evaluated across four comparisons: Multiple sclerosis (MS) females vs. MS males; sex-matched MS vs. control groups; and female vs. male healthy controls. Distinct sex-biased miRNA signatures emerged. Males with RRMS demonstrated dysregulation of immune-associated miRNAs, including coordinated changes in the miR-29, miR-30, and miR-199 families. Females with RRMS exhibited consistent downregulation of miR-941 and differential expression of immune-associated miRNAs including miR-223-3p, miR-485-3p, and miR-199a-5p. Several immune-regulatory miRNAs, including miR-223-3p, miR-146a-5p, miR-196b-5p, and miR-183-5p, were differentially expressed in both healthy controls and disease-related comparisons, suggesting that sexually dimorphic immune regulatory programs may precede disease onset. These findings indicate that disease-associated miRNA alterations are superimposed on pre-existing sex-specific immune networks and underscore the importance of incorporating sex as a biological variable in biomarker discovery and precision medicine for MS.

Abstract: PubMed · Datensatz

Bibliografischer Nachweis

Publikationsdaten

Autor:innen
Nicht angegeben
Quelle
CrossRef Listing of Deleted DOIs
Publikation
2015-01-01
Band / Ausgabe
Nicht angegeben
Seiten
Nicht angegeben
ISSN / ISBN
0849-6757
Zitationen
0 laut Crossref
Referenzen
0 hinterlegt

Zitieren

Zitierfähiger Nachweis

(2015). 10.1177/1056789514562152. CrossRef Listing of Deleted DOIs. https://doi.org/10.1177/10998004261473903
RIS BibTeX CSL-JSON